Prime Therapeutics rises to Minnesota's No. 2 largest private company as pharmacy costs rise
CEO Ken Paulus said the company ’s steady growth has largely been driven by increases in pharmacy spending, specifically for prescription medications used to treat complex conditions including oncology, autoimmune and rare diseases.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Carter Jones Source Type: news
More News: Autoimmune Disease | Biotechnology | Cancer & Oncology | Health Management | Rare Diseases